DHAI (DIH Holding US) FCF Yield %: 0.00 (As of Jun. 27, 2026)


What is DIH Holding US FCF Yield %?

DIH Holding US DHAI FCF Yield % is 0.00 as of Jun. 27, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, DIH Holding US's Trailing 12-Month Free Cash Flow is $-4.68 Mil, and Market Cap is $0.00 Mil. Therefore, DIH Holding US's FCF Yield % for today is 0.00%.

The historical rank and industry rank for DIH Holding US's FCF Yield % or its related term are showing as below:


DHAI's FCF Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.38
* Ranked among companies with meaningful FCF Yield % only.

DIH Holding US's FCF Margin % for the quarter that ended in Mar. 2025 was -26.79%.

DIH Holding US FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

DIH Holding US FCF Yield % Related Terms

DIH Holding US FCF Yield % Historical Data

* Premium members only.

The historical data trend for DIH Holding US's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US FCF Yield % Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
FCF Yield %
0.00 0.00 328.25 -47.89

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -243.36 43.87 138.27 -138.68

DHAI vs ABT, SYK, MDT: FCF Yield % Comparison

For the Medical Devices subindustry, DIH Holding US's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DIH Holding US FCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's FCF Yield % distribution charts can be found below:

* The bar in red indicates where DIH Holding US's FCF Yield % falls into.


DIH Holding US FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

DIH Holding US's FCF Yield % for the fiscal year that ended in Mar. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.68 / 9.772425
=-47.89%

DIH Holding US's annualized FCF Yield % for the quarter that ended in Mar. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.388 * 4 / 9.772425
=-138.68%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
DIH Holding US (DHAI) has a FCF Yield % of 0.00 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's FCF Yield % too high?
DIH Holding US's current FCF Yield % is 0.00.
How does DIH Holding US's FCF Yield % compare to ABT and SYK?
DIH Holding US's FCF Yield % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DIH Holding US and its competitors. DIH Holding US's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For DIH Holding US (DHAI), the current FCF Yield % is 0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.